Gaucher Disease: Retrovirus-mediated Correction of the Enzymatic Defect in Cultured Cells

  1. J. Sorge,
  2. W. Kuhl,
  3. C. West, and
  4. E. Beutler
  1. Scripps Clinic and Research Foundation, Department of Basic and Clinical Research, La Jolla, California 92037

This extract was created in the absence of an abstract.

Excerpt

Gaucher disease is a lysosomal storage disorder caused by abnormally low glucocerebrosidase enzymatic activity in cells of the macrophage lineage (Desnick et al. 1982; Brady and Barranger 1983). The disease is linked to a single genetic locus and is inherited in an autosomally recessive manner. The overall gene frequency in the United States is roughly 1/500, but it is approximately 10 times higher in the Jewish population. Gaucher patients present a variety of signs and symptoms due to the accumulation of glucocerebroside in the reticuloendothelial system. Splenomegaly, hepatomegaly, and bone fractures are frequent manifestations of the most common, type I form of the disease. In the type I form there are no neurological manifestations. The less common, type II or juvenile form of the disease always affects the central nervous system. The severity of the type I disease is highly variable; some diagnoses are made before the age of 5,...

| Table of Contents